The Science Behind Nootropics: How Smart Pills Work
The nootropics market was estimated at USD 10.7 billion in 2021 and is likely to grow at a CAGR of 15.07% during 2022-2028 to reach USD 28.66 billion in 2028.
Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.
Read More: https://www.stratviewresearch.com/1647/nootropics-market.html
The nootropics market was estimated at USD 10.7 billion in 2021 and is likely to grow at a CAGR of 15.07% during 2022-2028 to reach USD 28.66 billion in 2028.
Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.
Read More: https://www.stratviewresearch.com/1647/nootropics-market.html
The Science Behind Nootropics: How Smart Pills Work
The nootropics market was estimated at USD 10.7 billion in 2021 and is likely to grow at a CAGR of 15.07% during 2022-2028 to reach USD 28.66 billion in 2028.
Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.
Read More: https://www.stratviewresearch.com/1647/nootropics-market.html
0 Комментарии
0 Поделились
0 предпросмотр